PURPOSE :

We aimed to assess the usefulness and safety of the God’s Hand pneumatic compression device for hemostasis in patients undergoing percutaneous endovascular procedures via femoral artery.

METHODS:

Two hundred thirty-seven patients in whom hemostasis of femoral catheterization was achieved using a God’s Hand pneumatic compression device were enrolled. The patients were divided into group A, those in whom the device was applied for four hours, and group B, those in whom the device was applied for two hours, with an additional two hours of bed rest in both groups. Groups A and B were regrouped to groups A’ and B’ using the propensity score matching method (n=65, for both). Chi-squared test and logistic regression models were used to analyze the relationship between the complication rate and patient characteristics and procedure-related factors.

RESULTS:

Clinical success was achieved in 216 of 237 patients (91.1%): 63 in group A (84%) and 153 in group B (94.4%); in propensity score matched groups, clinical success was seen in 47 patients in group A’ (81.5%) and 62 patients in group B’ (95.4%). Group B’ showed a higher clinical success rate than group A’ (P = 0.028). There were no major complications. In logistic regression models, a negative association was noted between the complication rate and the duration of God’s Hand application; however, this association was not statistically significant.

CONCLUSION:

The God’s Hand pneumatic compression device is effective and safe for the hemostasis of femoral catheterization, and four hours of bed rest is sufficient for hemostasis in selected patients.